Sign Up to like & get
recommendations!
1
Published in 2022 at "Vascular pharmacology"
DOI: 10.1016/j.vph.2022.106969
Abstract: Sdox is a synthetic H2S-releasing doxorubicin (Dox) less cardiotoxic and more effective than Dox in pre-clinical, Dox-resistant tumour models. The well-known anthracycline vascular toxicity, however, might limit Sdox clinical use. This study aimed at evaluating…
read more here.
Keywords:
h2s releasing;
hy926 cells;
sdox;
h2s ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0191477
Abstract: Background Ethyl pyruvate (EP) exerts anti-inflammatory and anti-oxidative properties. The aim of our study was to investigate whether EP is capable of inhibiting the oxidation of LDL, a crucial step in atherogenesis. Additionally, we examined…
read more here.
Keywords:
hy926;
ethyl pyruvate;
hy926 cells;
oxidation ldl ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms18010095
Abstract: Sailuotong (SLT) is a standardised three-herb formulation consisting of Panax ginseng, Ginkgo biloba, and Crocus sativus designed for the management of vascular dementia. While the latest clinical trials have demonstrated beneficial effects of SLT in…
read more here.
Keywords:
peroxide h2o2;
hydrogen peroxide;
h2o2;
h2o2 induced ... See more keywords